# Nedaplatin in Treatment for Nasopharyngeal Carcinoma

> **NCT04834206** · PHASE2 · COMPLETED · sponsor: **Affiliated Cancer Hospital & Institute of Guangzhou Medical University** · enrollment: 32 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Docetaxel, nedaplatin, fluorouracil
- **RADIATION:** IMRT
- **DRUG:** Nedaplatin

## Key facts

- **NCT ID:** NCT04834206
- **Lead sponsor:** Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2021-10-29
- **Final completion:** 2022-05-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834206, "Nedaplatin in Treatment for Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04834206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*